Navigation Links
LenSar: New Laser Cure for Cataracts
Date:11/5/2009

NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- A new laser therapy that can potentially remove cataracts from people's eyes more efficiently and with greater precision was presented on October 24, 2009 at the American Academy of Ophthalmology (AAO) annual meeting. The technology, currently undergoing clinical trials outside the USA, was developed by LenSar, a start-up company which is in a head-to-head competition with two other players to be the first to commercialize the technology. LenSar plans to start treating patients if the FDA will consider the results of the remaining trials to be both safe and effective.

Although the new device will cost more than existing technologies, the speed of surgery may compensate for that by allowing more procedures to be performed in less time. The new LenSar laser cataract device is designed to be safer and easier to use, and it is believed that most cataract surgeons can learn to use it to perform surgeries with less complications. The laser will allow for the use of "premium" implants which set up bifocal vision as well as provide a better way to treat astigmatism.

Cataracts are presently treated with a devise known as a Phacoemulsifier, which uses ultrasound waves to break up the contents of the cataract and was nicknamed in the mid-seventies a "laser". This 35 years old device is generally very safe, however results are largely dependent on the individual surgeon's skills. LenSar suggests that their laser will make cataract surgery easier to perform, perhaps transforming average eye surgeons into surgeons equipped with safer and better technology, benefitting the three million patients who undergo cataract surgery annually in the U.S.

LenSar's CEO, Randy Frey, Ph.D., a well-acclaimed scientist known best for the Lasik laser he developed, formed LenSar in 2004 which has had about 100 operations performed outside of the U.S. with promising results. Although his cataract laser concept has spurred competing companies, Frey claims that he holds important patent applications which allow the company to focus on R&D and pay less attention to competitors. It is his belief that LenSar's patents will prevail and will have a legal claim on any such devices, regardless of their maker.

The real financial benefit for LenSar is not in the sale of the laser but in the "royalty-like" fee that is paid to the company each time the laser is used. Laser eye surgery devices by companies such as Alcon, Bausch and Lomb, and AMO have generated billions in revenue using this "click fee" strategy.

SOURCE LenSar


'/>"/>
SOURCE LenSar
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
2. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
3. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
4. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
5. DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
6. Blue Light Destroys Antibiotic-Resistant Staph Infection - Results Reported in Photomedicine and Laser Surgery Journal
7. Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds
8. New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation
9. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
10. Pivotal Clinical Data Published for the Only Laser Phototherapy Device Cleared by the FDA for Hair Growth
11. Published Study Shows VNUS ClosureFAST(TM) System Significantly Superior to Laser for Varicose Vein Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... Conference at the Grand Hyatt hotel in New York.  ... at 11:40 a.m. Eastern Time. A live ... Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... WILMINGTON, Del. , Sept. 6, 2017 NeuroRx, ... for Acute Suicidal Ideation and Behavior (ASIB), has been granted ... for its sequential therapy of NRX-100 (ketamine HCl) followed by ... patients in a pivotal trial of this sequential therapy targeting ... bipolar depression. 1 ...
(Date:9/5/2017)...  Just 18 months after its February 2016 launch, ... the appointment of three new senior people to its ... Jones-Phillips and James Wright bring decades ... Tammy Wynne joins as Director, ... She has over ten years, experience in global market ...
Breaking Medicine Technology:
(Date:9/22/2017)... , ... September 22, 2017 , ... ... Rob Lowe, explores the world of Alzheimer’s. Alzheimer’s is a disease estimated to ... This according to information published by the Alzheimer’s Association, a leading voice in ...
(Date:9/22/2017)... Encino, CA (PRWEB) , ... September 22, 2017 ... ... ways to preserve fertility and create life. Although frozen embryos have a slight ... circumstances. , “Egg freezing is a wonderful opportunity for women undergoing medical ...
(Date:9/21/2017)... ... ... SABRE is raising awareness about personal safety with a Chicago Transit Authority ad ... Chicago, Illinois, based self-defense brand has been waiting for an opportunity like this to ... personal safety into their own hands. , The ads focus on their diverse line ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is ... and give back to the community. For over 37 years, they have operated with ... serving plumbing in San Diego. They were chosen as the Best San ...
(Date:9/21/2017)... New York (PRWEB) , ... September 21, 2017 , ... ... named “One Yoga Mat Revolution” on 6th, 7th and 8th October at Miranda Kuo ... renowned yoga mat art pieces, such as Zen Kodo mat. Wanderlust , one ...
Breaking Medicine News(10 mins):